Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Probiotic (Sabular) vs rosuvastatin added to quadruple therapy for Helicobacter pylori eradication
IRCT20230827059280N1Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Dec 2023
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of rosuvastatin in Helicobacter pylori infection (2 arms), sponsored by Isfahan University of Medical Sciences. Started Dec 2023; status: completed.
02
Drugs
rosuvastatin
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on IRCT20230827059280N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20230827059280N1.